We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis Garners Pediatric Exclusivity for Diovan
Novartis Garners Pediatric Exclusivity for Diovan
August 17, 2007
The FDA has granted Diovan pediatric exclusivity based on studies conducted in children with high blood pressure, Novartis announced.